Adam Schenck, Milliman
A Couple Retiring Today Needs $600,000 for Healthcare
Adam Schenck walked into Milliman as an intern in January 2005, coming in on Fridays while he finished a master's in financial mathematics at the University of Chicago. His peers went to banks and hedge funds. He stayed at an actuarial firm. One of his first jobs was helping a life insurer price a complex derivative that banks were selling to insurers as a hedge. He became the first trader in Milliman's financial risk management group, and he was standing next to that desk in 2008 while the team moved insurers' derivatives off Lehman Brothers and onto other banks. Milliman is an 80-year-old actuarial consulting firm. Adam's line is that they shoehorned an asset manager into it.
This April that asset manager launched its first two ETFs under the Milliman name. Both go after one problem. Healthcare costs keep rising faster than your clients' paychecks.
The Number Nobody Plans For
Milliman publishes a retiree healthcare cost index. Take a 65-year-old on original Medicare, a Plan G Medigap policy and Part D drug coverage. Over retirement that comes to about $297,000 for a man and $340,000 for a woman. A couple needs more than $600,000, and that excludes long-term care and dental. The figure rose about 7% from last year's study. And that is with Medicare. Adam thinks a lot of people miss this. Medicare is the backstop, and you still need real savings to pay for a basic plan on top of it.
Working years aren't cheaper. The Milliman Medical Index puts a family of four on a typical employer plan at about $37,000 a year, all in. Milliman has measured that number since 2005, and it has grown more than 6% a year. That is well above most people's raises, and well above what Treasuries or TIPS pay.
Follow the Money
The target is a third Milliman index that tracks healthcare claims inflation. Actuaries call it trend, and it has run close to 7% over the last five years. One fund tries to match trend. The other aims for trend plus 2%, and takes more equity risk to get there.
The portfolio has four parts. The first is healthcare stocks, picked by what Adam calls a follow the money approach. Find what is driving costs up and own the companies on the receiving end. Right now that's drugs, so pharma is overweight and Eli Lilly is the top holding. Hospitals and professional services are flat, so they get less. The second part is broad equities, because inflation in the rest of the economy feeds into healthcare too. Third is gold, to soften equity drawdowns. Fourth is a Treasury strategy tuned to track wage inflation. Adam says gold and Treasuries together have tended to keep pace with wages over time.
The part I found most interesting is the timing. A claim takes about five months to settle between the insurer and the provider, so Milliman's actuaries produce a nowcast of where trend sits today. Every month the fund rebuilds the portfolio with the least risk it needs to hit that number. Every week an AI layer scans the FDA, CMS, state regulators and court filings for company problems. A device recall is the kind of thing that gets a stock trimmed before the monthly rebuild.
Where It Fits
I asked Adam which bucket this belongs in. His answer was none of them. Take it from everything. Start with Milliman's online calculator: age, retirement age, state, health status from one to four stars, plus a spouse. It gives you the future cost and a present value in today's dollars. That present value is the amount he'd put in the sleeve. Then redo it every year, like a checkup. I liked one detail. The healthiest clients can need the most, because they tend to live longest.
He was also blunt about cash. In the historical scenarios Milliman has measured, cash almost always fell short of healthcare inflation. The one exception was COVID, when people put off care. Then trend shot straight back up.
The institutional angle is the bigger idea to me. Insurers and employers collect premiums and pay claims two weeks later. Adam is pitching them on funding a reserve and holding those dollars in something that moves with the cost it has to pay. He admits it's well outside what they usually do.
For advisers it's simpler. Where in your client's plan does the $600,000 live today?
Talk it through
THOR builds adaptive index strategies for advisers and allocators. Fifteen minutes with our founder and CIO gets you the mechanism, the index history, and an honest read on where it fits. Book a time.
Full Transcript
4,075 wordsMachine transcribed from Brad Roth's conversation with Adam Schenck, Milliman. Timestamps link to that moment on YouTube. Lightly cleaned, otherwise unedited.
Hey, Adam. Welcome to the show. Thanks for having me. Before we get started, why don't you give everybody a bit about your background? University of Chicago for your master's in financial mathematics. You're also a CFA. You've been with Milliman since 2005. Can you walk us through how that entire path unfolded? Yeah. I got to Chicago in 2004 for grad school, as you mentioned, after doing an undergrad in computer science and math at Eckerd College down in St. Petersburg, Florida. I was born and raised in Kentucky. I ended up here and then started as an intern at Milliman in January. I was coming in on Fridays.
And I just really liked the work. So as a lot of my colleagues were going to the banks and hedge funds and the rest, I really liked the work that they were doing here at Milliman. So back then, and still what our practice does today, we were helping life insurers. And one of my first roles was helping a life insurer price a very complex derivative that the banks were selling them as a hedge for the products that they were selling to their policyholders. So yeah, a lot of background in financial derivatives. And this is actually an 80-year-old actual consulting firm.
And we've now shoehorned an asset manager in there. So it's been a pretty exciting ride. So before we get into Milliman a little bit deeper, I always like to ask everybody, outside of work, what are you doing when you're not behind the desk? Yeah, so I have lots of hobbies. Probably number one and two on the list are I got into water sports down at Eckerd. So I do wake surfing here in Chicago when the wind is right and the lake is calm. And that's done behind a wake boat that produces a perpetual surf wave.
So it makes it, it's not real surfing, but it definitely feels like it. And then that's kind of transitioned to foiling. So I have an e-foil, if you've ever seen that. And then next on the list would be snowboarding. So in the winter, I tend to try to get out snowboarding. So, yeah. Yeah, so I'm the opposite of you, a water ski and ski. So you do things sideways. I do things front to back. Indeed. Yeah, it's cool. And so most people know Milliman, as you said, it's one of the largest actuarial firms in the world. You guys were found in 1947, but fewer people know that your risk management department advises around $242 billion in assets.
Read the full transcript (34 more sections)Collapse transcript
So can you give us the quick high level on who Milliman is and how the investment side really fits in? Yeah. As you mentioned, we started in 1947 by two pension actuaries. And so they continued to grow the business in different areas of focus. We call those disciplines. So there's four disciplines. Life. So we're within the life disciplines I'll talk about in a second. Health. And the health actually started very shortly after employee benefits, which was the pension. And then we had a record keeper. We actually sold that to Empower this year.
And the fourth is property and casualty. So health emerged in the 50s and then life shortly thereafter. And so our practice in financial risk management was born out of the Chicago mergers and acquisitions practice that helped life insurers with M&A and other traditional life consulting. That happened in the late 90s because insurers then started to sell products linked to the financial markets, not just fixed annuities, that are bright guarantees, but actually guaranteeing an investment return on a portfolio of stocks and bonds.
So we then helped them understand how to hedge that like a bank would. And then we initially it was consulting and software. And then some of the small and midsize insurers didn't want to start up a trading floor and actually go out and execute those trades. So they handed the keys end to end of those trading strategies to us. And then we started to implement those on their behalf. So that was in the mid aughts. And then that took us into the financial crisis. So we were hedging for those insurers in the GFC. I remember I was I was at Milliman and standing next to the trading.
I was actually our first trader. And then we hired more folks. And I went back to focusing on the quantitative finance side. No standing next to our desk because we're trying to innovate some of the more complex derivatives from Lehman Brothers to other banks that the insurers were holding. Right. So we were right in the thick of it, saved the insurers a bunch of money that were using our techniques to hedge. And then we started a fund business in 2010, which implemented the same risk management techniques we were doing for the balance sheet of insurers inside of the funds.
So that's how we developed a pension for risk management inside of mutual funds. And then that led us to the ETF industry. So these are ETFs, Milliman's first ETFs. And so just out of curiosity, before we talk about the two of them, why ETFs and why start in health care? So. We as we were looking at this problem and we started looking at this problem with our colleagues in health. A little over three and a half years ago. And we found that this is really kind of endemic to both institutions and individuals.
The rising cost of care is affecting everybody. So not only those that are trying to insure it, but those are trying to save for it. And if you actually our mission statement is to serve our clients, to protect the health and financial well-being of people everywhere. So that people everywhere part is why we thought, you know what, let's actually launch it in the ETF wrapper because that can serve both of those use cases. Right. And then, as far as why health. So we have a lot of expertise in health. In fact, out of those four disciplines I named, health is the biggest as far as revenue.
So we work for most of the large organizations in the health care system. And I would say the most overall. There's many organizations from the biggest insurers all the way down to, these tiny accountable care organizations. We work with the drug manufacturers on, helping them figure out the research budgets and all of those things. And that actually started in the 50s. And one of the things they produced way back then that we still produce today, which is a big linchpin on the strategy, is looking at trends in health care cost inflation and then reporting those trends to clients.
So these are very Milliman, the strategy and the client base. And then, the things that we look at every day are very Milliman. So that's why we thought, we should put the Milliman name on these, right? Because we are definitely the experts in health. And then with our pension and risk management, really, that's why the name Milliman belongs on these. And we're going to have to educate people on who Milliman is because we've always been in the background, right? But, that's essentially what enabled that decision. Well, let's get into the funds. You launched two. There's MHIG, which is the Healthcare Inflation Guard ETF.
You also launched MHIP, which is the Healthcare Inflation Plus ETF. Pretty recently launched here in April, both actively managed. At a high level, what are these funds and what problem are they solving? Okay, so the problem, we'll start there, is the rising cost of care. So we actually put out two indices that measure this differently for individuals. So the first one I'll cite is the Milliman Retiree Healthcare Cost Index. That measures how much money a individual or a couple will spend over their retirement lifespan.
So once they retire to when they pass. And the total spend over that period for a male with the original Medicare plus Medigap, which is Plan G, plus the Medicare Part D, the drugs, is $297,000 for a male and $340,000 for a female. So over $600,000 for a couple in retirement. And that's up on the order of 7% from last year's study and certainly rising over time.
And that's with Medicare, right? I think that's what a lot of people don't understand is even if you have that backstop, you still have to have money saved in order to pay for a really basic plan. So that's in retirement. The next one is that we put out is called the Milliman Medical Index. And the Milliman Medical Index measures the cost of providing either an individual just on a corporate healthcare plan. So all of your deductibles out of pocket, everything like that. And then also a typical family of four. So that number for this year was $37,000 for a family of four is how much one needs just in a corporate health plan and $8,460 for an average person.
So the rate of inflation in that number that we've been measuring since 2005 is over 6% per year. So well above someone's typical raise if they're trying to fund this just out of their salary. So the ETFs, so how do we try to address this problem with an investment strategy? So obviously that rate of inflation is well more than tips, is well more than treasuries, right? You have to end up taking some risk in order to get to higher returns. So the way that we do that is there's a third index we publish.
And the third index tracks claims inflation. So we actually look at claims that are, we buy data and we get data from providers. So from health plans, and then we track how much the claims are increasing over time. And we call that, healthcare actuaries call that trend. So the trend in those claims kind of matches what we see in the medical, minimum medical index. So anywhere from 5% to 6%. It's lately been running well over that. It's almost 7% in the last five years or so. So the health trend guidelines index, that's what that index is.
We use that as our bogey for the strategy, okay? So the strategy then seeks to meet that rate of return to try to match that bogey over time by investing in healthcare equities. But in healthcare equities in a specific way where we identify, I like to call it a follow the money strategy. We try to identify the companies that benefit when certain trends in inflation are high in healthcare, right? So right now, the trends are high because of drugs. So we're identifying the companies that are benefiting from the drug costs.
And the biggest one right now is Lilly, for example. And that's our biggest holding in the healthcare space. So that's healthcare equities. There's also a layer that we call a supply chain, which is broad equities. So that's all the other things that could cause inflation in a lot of things. So technology gets more expensive or other things kind of in the broader economy get more expensive. That also pushes up healthcare inflation. Then we have diversifier bucket. And the diversifier that we've chosen serves really two purposes. So one is to reduce the equity exposure in a drawdown. So we want something that tends to not be correlated to equities in a drawdown and has potential to appreciate.
And that's gold. But then we also like gold because when paired with our treasury, which is our de-risking bucket, gold plus treasuries tends to keep up with wage inflation over time. And then our final bucket is a treasury strategy in particular that we dial in in order to try to match wage inflation. So that's how we kind of construct the portfolio to build up to how we seek to meet that level of healthcare inflation. And that's the guard strategy I just described. And then for plus, the plus aims 2% above that health trend every single month.
And we rebalance that approach. Some things on a weekly basis, everything else on a monthly basis when we get the new reading from our healthcare actuaries. So plus, it shoots 2% above the bogey by taking more risk necessarily in equities, but in the same general way to try to outpace inflation over time. Okay. So let me try to simplify this for the advisors and the listeners. So MHIG is the bogey, right? You're going to try to match the cost of inflation in the healthcare sector. The MHIP is the bogey plus two.
And you're going to do that by taking more risk. So very interested in how you're putting this strategy together in order to do that. Because your team has a ton of experience. You guys have spent years on volatility and risk management and 40-act portfolios. But you're kind of taking this portfolio mix from what I'm hearing in healthcare equities, broad equities, treasuries, tips, corporates, gold now, and commodities. So how do those pieces come together? Can the strategy kind of go anywhere depending on vol and risk? And I'm really interested to learn how these levers move. Yeah. Yeah. So every single month, we have a projected that we get from our actuaries, a projection on what the trend is right now.
Now, that is based on what has happened roughly five months ago. So when you submit your claim to your doctor, it takes a while for it to get resolved and fully paid. Sometimes there's a back and forth between the insurer and the provider. So all of that stuff resolves roughly five months later. So we get essentially what's like a now cast of that healthcare inflation. What is it likely trending at right now? Given that, and then given our model's expected return assumptions for those asset classes, we assemble the portfolio with the least amount of risk possible in order to meet that objective over that month.
And then we do the same thing month over month over month. And then we also have other features in the equity side that try to help control volatility and drawdown per specific security. So we're trying to identify the securities that are experiencing, maybe some device manufacturer has a recall and it's, that stock is experiencing a drawdown. So our systems are constantly monitoring all that and pulling away from that stock and putting into something else that may not have so much of an issue that's more correlated with the inflation that we're seeing over time.
So basically, we're taking as much risk as we need to, but not more to seek our objective. So it seems to be like your edge here is the fact that you, the, the closeness to the data and the history in which you guys have, have been doing this, which, gives you that edge. Just curious, is that monthly rebalance like a fully rules-based approach? And then those, we'll call them, additional drawdown protection. Is that inter-month or is that, is that also rules-based or there, you have analysts on this, like just kind of curious of the construction and I guess monitoring, a continuous monitoring of the product.
Yeah. So it's all data-driven. So we don't have a analysts that are, that are going through all this data because it is so significant. But what we've built into our strategy is the ideas that our health colleagues have had over time, right? So we, we are, we are using some AI in this to help understand when a particular company is having a problem, right? And, may need to be kind of backed away from due to some regulatory activity. So we're monitoring information from the CMS, from the FDA, from state regulators, even legal filings and, and things like that in order to understand the idiosyncratic risk in each of the individual companies.
And then we're also using the claims data to understand the drivers of inflation right now. And so we're allocating, over allocating to those companies versus the ones that are not really driving inflation right now. So for example, right now we're seeing pharma trends are really high, but then hospital and professional services are, are kind of flat. So we're allocating, over allocating to pharma versus the, the companies that are sensitive to those other approaches. The, um, the, the risk management, uh, with, kind of the, the, um, those sentiment factors from regulators that I described and, and then other factors is done on a weekly basis.
And then the full portfolio is allocated on a monthly basis. Got it. So you mentioned like very early on you guys over at Milliman estimate 65 year old couple retiring today needs, let's just call it around 600,000 for healthcare, healthcare, excluding long-term care and dental. So like, I know this isn't a financial planning show, but like, how should someone be planning for retirement thinking? How, how should they be thinking about using your funds to help cover that additional cost as they start to age into it? So we've got a calculator on our website and we think it's, it's a very simple calculator, but we think it can help people start to understand just how much they might need.
So, uh, in the calculator, you put your current age, the expected age you want to retire, um, the state that you want to retire in, or you can take the national average. And then there's a health status from, one to four stars. And that actually is kind of an interesting, uh, parameter because sometimes the healthier you are, the longer you'll live and therefore the more, more money you'll need. Right. So, uh, but you put all that in and then you can choose to include your spouse and then you put the same things in for your spouse. And then you click generate and it'll spit out a value in future dollars of the same thing, like how much you're going to need to spend in future dollars when you, from when
You retire to when you pass. Um, and then what I think is, is really relevant for an investment strategy. We do the present value of that. So what does that look like in today's dollars, assuming a rate of inflation that we calculate from our health trend guidelines? So that's 6.8% right now in the tool. That's the last five years of health trend guidelines, but it really doesn't matter because that both inflates the money and then brings it back to today's dollars. So really that today's dollars look at how much that money is, in the future, that's essentially what we think you should put into these strategies, because that is the amount that you need to cover future healthcare expenses.
And that's what needs to be essentially sensitive, right? It needs to appreciate if healthcare inflation goes up, if it, if healthcare inflation goes down, you're winning. So you don't need to have as much return and so on and so forth. So that's how we're, we're hoping people can, uh, can use these. And then also the reason we launched too is, is kind of also the dual mandate. So some of the institutions we've talked to might use the plus strategy because they have a higher risk tolerance and also for individuals. If you have a higher risk tolerance and you want to try to, maybe bank some of those returns earlier in your investing, investing life span, then you can choose the plus versus the guard.
Um, and kind of have a, a little bit of a glide path there. So that's essentially how we're hoping folks can use it to help save for, uh, healthcare expenses. And I think the use case, just think, just listening to you talk goes like well beyond just individuals, right? Health insurers, providers, employer health plans, like even government entities. Like how does an institution look at this as a healthcare hedge, like inflation hedge, like in their use case, rather than just an individual, which is kind of a more of a simple use case. Absolutely. And we're talking to a lot of those folks now and, uh, it's really resonating, but this is so outside the box of what they normally do, right? Normally what they do is they set their premium and they collect their premium every single,
Out of people's paychecks. And then it goes out the door two weeks later and claims, right? So you do have to change that paradigm a little bit. And for some that can pre-fund an investment in this strategy, they can do that as essentially a reserve. And then they can, uh, essentially denominate their healthcare dollars in the ETF in order to participate in the same, uh, sensitivity that we can enable with, with the strategy. So, because what we know is that cash has literally never kept up with healthcare cost inflation in any of the historical scenarios we've measured.
It always, it's, it's mostly always fell short. I, I take that back. In COVID, uh, that's the only period where we saw general healthcare trends decline. So cash would have outpaced then. And that's really the only scenario because, uh, it, it shot right back up after everybody said, okay, that, the coast is clear. I'm going to go get my surgery. I'm going to go, back to the doctor and get my checkup even. Right. So, um, so yeah, that's, that's kind of the, the, the rub with all this, but yeah. So institutions right now are, we're trying to help them understand how they can use this as a hedge, but certainly that's really what this is, is a, is a hedge to inflation by trying
To participate in the companies that are benefiting when the inflation is high. So for an advisor who's thinking about using this in their practice, advisors like buckets, right, I've got my equity bucket. I've got my fixed income bucket. I've got my alts bucket. is this a bolt on alongside equities? there's a lot that goes into this fund. Is it an alts? where would you kind of guide them to think and how to think about using these in a, in a diversified model portfolio? So I think they should take carve out from everything, right? So really, so figure out that number for your client.
What do they need in today's dollars, to invest in order to keep up with healthcare cost inflation over time? And actually, I would say, just like you do your doctor's checkup in a year, do the checkup again. What is your health status? Have you changed your retirement expectation? Have you changed any of that? And how much do you need then? And then what, in terms of that bucket, that healthcare cost savings bucket, how much did the fund appreciate it? Do you need to top it up? Or do you, can you take some off of it? But I do think it should be a specific sleeve in their allocation, right? Just dependent on those factors of how much they need to save at any given point in time.
So I think you take it from everything because, the, again, in this portfolio, everything has a purpose and it is ultimately MHIG especially is a conservative portfolio. In fact, the benchmarks for it, if you look at our website or the, is the ag aggregate bond index and tips, right? So. Well, Adam, I really appreciate you spending some time with me today. These are very interesting and unique products. Before I can let you go though, where can people learn more about Milliman and these two ETFs? Certainly. Just go to millimanfunds.com or millimanetfs.com. All the information there.
We've got some research. We've got the calculator that's right there for you to play with. And then you can take a look at both those funds. Well, again, thanks, Adam. Okay. Thank you.
Daily Market Intelligence
The Signal
Brad Roth's daily market brief — systematic signals, ETF positioning, and what the data is actually showing.
Subscribe Free →